Singapore Markets closed
BANKS

DBS CEO says tough for digital banks to muscle into Singapore

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
34.22-0.61 (-1.75%)
At close: 04:00PM EST
34.22 0.00 (0.00%)
After hours: 06:03PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 362.16
52-week low 332.47
50-day moving average 343.65
200-day moving average 349.80

Share statistics

Avg vol (3-month) 3436.2k
Avg vol (10-day) 3645.36k
Shares outstanding 561.57M
Implied shares outstanding 6N/A
Float 869.21M
% held by insiders 11.18%
% held by institutions 1108.24%
Shares short (14 Jun 2021) 44.45M
Short ratio (14 Jun 2021) 49.59
Short % of float (14 Jun 2021) 411.61%
Short % of shares outstanding (14 Jun 2021) 47.23%
Shares short (prior month 13 May 2021) 45.11M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin 781.12%
Operating margin (ttm)-157.65%

Management effectiveness

Return on assets (ttm)-12.18%
Return on equity (ttm)-22.87%

Income statement

Revenue (ttm)203.2M
Revenue per share (ttm)2.93
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-167.08M
EBITDA -310.35M
Net income avi to common (ttm)-334.15M
Diluted EPS (ttm)22.93
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.34B
Total cash per share (mrq)33.4
Total debt (mrq)103.61M
Total debt/equity (mrq)4.51
Current ratio (mrq)24.40
Book value per share (mrq)32.90

Cash flow statement

Operating cash flow (ttm)-306.15M
Levered free cash flow (ttm)-74.53M